Changeflow GovPing Financial Regulation BaFin Warns Equity Research Ventures Over Prosp...
Urgent Enforcement Added Final

BaFin Warns Equity Research Ventures Over Prospectus

Favicon for www.bafin.de BaFin News
Filed March 13th, 2026
Detected March 13th, 2026
Email

Summary

Germany's BaFin has issued a warning regarding Equity Research Ventures PTE. LTD. for allegedly offering capital investments without a required prospectus. The company is accused of soliciting public investments in Germany for a product named 'Co-Investment AlleAktien Wealth x SpaceX' without BaFin's approval.

What changed

The Federal Financial Supervisory Authority (BaFin) has issued a warning against Equity Research Ventures PTE. LTD., a company purportedly based in Singapore, for offering capital investments to the German public without a prospectus. BaFin has evidence that the company is soliciting investments for "Co-Investment AlleAktien Wealth x SpaceX" through various websites without having obtained the necessary prospectus approval from BaFin, and there is no indication that any exemptions apply.

This action highlights the strict prospectus requirements in Germany for public offerings of capital investments, which mandate BaFin approval to ensure minimum information disclosure and understandability. Regulated entities and investors should be aware that offering such investments without an approved prospectus is a violation. BaFin encourages individuals with specific information about the offeror to contact their whistleblower point. While BaFin does not verify the accuracy of prospectus information or issuer reliability, the absence of an approved prospectus is a critical deficiency.

What to do next

  1. Verify if "Equity Research Ventures PTE. LTD." or "AlleAktien" is soliciting investments in your jurisdiction.
  2. Confirm that any public offering of capital investments in Germany has an approved prospectus filed with BaFin.
  3. Report any suspected violations or provide information to BaFin's whistleblower contact point.

Source document (simplified)

Erscheinung: 13.03.2026 | Topic Consumer protection, Prospectuses Equity Research Ventures PTE. LTD. („AlleAktien“): evidence indicates no prospectus published

The Federal Financial Supervisory Authority (BaFin) has evidence indicating that Equity Research Ventures PTE. LTD., purportedly domiciled in Singapore, is offering capital investments under the name “ Co -Investment AlleAktien Wealth x SpaceX” to the public in Germany without the required prospectus. These capital investments are being offered in the form of “other capital investments” within the meaning of section 1 (2) no. 7 of the German Capital Investment Act (Vermögensanlagengesetz – VermAnlG) on the websites go.alleaktien(.)com/spacex, wealth.alleaktien(.)com/spacex and bettermarkets(.)app/waitlist.

There are no indications that the conditions for exemption from the prospectus requirement are met.

Background:

In Germany, capital investments may be offered to the public only if an associated prospectus has already been approved by BaFin. During the approval process, BaFin checks whether the minimum information required by law is included in the prospectus and whether its content is understandable, coherent and consistent. However, BaFin does not check whether the information contained in the prospectus is correct. Moreover, it does not check whether the issuer is reliable nor does it examine the product in question. Issuers of capital investments must ensure that this is clearly indicated in their prospectuses. The issuers are liable for the accuracy of the information contained in the prospectus.

You can check whether an approved prospectus for offers of capital investments to the public has been filed with BaFin by consulting the database Prospectuses filed on the BaFin website.

Please note:

BaFin performs its functions and exercises its powers exclusively in the public interest in accordance with section 4 (4) of the Act Establishing the Federal Financial Supervisory Authority (Finanzdienstleistungsaufsichtsgesetz – FinDAG). Due to their statutory obligation of confidentiality, BaFin ’s staff are not in a position to provide third parties with information regarding the progress and results of administrative proceedings.

However, there are ways in which you can support BaFin ’s work: if you have any specific information about the offeror mentioned above – such as contract templates, email addresses, telephone or fax numbers of contact persons or the offeror’s account details – please do not hesitate to get in touch with our contact point for whistleblowers.

Did you find this article helpful?

We appreciate your feedback Your feedback helps us to continuously improve the website and to keep it up to date. If you have any questions and would like us to contact you, please use our contact form. Please send any disclosures about actual or suspected violations of supervisory provisions to our contact point for whistleblowers.

We appreciate your feedback helpful less helpful Comment (max. 1000 characters): * Mandatory field

Navigation

Classification

Agency
Various
Filed
March 13th, 2026
Instrument
Enforcement
Legal weight
Non-binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Investors Financial advisers
Geographic scope
Germany

Taxonomy

Primary area
Consumer Protection
Operational domain
Compliance
Topics
Prospectuses Capital Investments

Get Financial Regulation alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when BaFin News publishes new changes.

Free. Unsubscribe anytime.